Genmab — Februar 2021
-
https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/91112_genmab_feb_18.JPG Genmab holder sig fint omkring den opadgående midterlinie og kurs 3000 ser stadig realistisk ud inden for kommende 8-10 mdr
-
Nature, Blood cancer journal - Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment https://www.nature.com/articles/s41408-021-00430-6
-
God morgen.
-
Asien: Høje renter begynder at tynge investorernes indstilling - NY: https://www.proinvestor.com/investornyt/672302/asien-hoje-renter-begynder-at-tynge-investorernes-indstilling-ny
-
Fredagens aviser med Vestas, Tryg og
Arlahttps://www.proinvestor.com/investornyt/672299/fredagens-aviser-med-vestas-tryg-og-arla -
God morgen
-
-
-
Updates in MM in the frontline settings. https://www.onclive.com/view/multiple-myeloma-talk-a-review-of-data-from-the-ash-2020-virtual-meeting?seriesVid=1
-
Så kom der et lille TA triangle signal igår som indikere risiko for nedtrend mod 2390 https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/91139_2390_gmab.JPG
-
Stock..så er det spædende om vi er over eller under 2390 på onsdag.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind